Press release
A combination of anti-aging drug increases the lifetime of mice by 30% and gives promise for human longevity
anti-aging drug
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72631
Market Overview
The global anti-aging drugs market was valued at USD 6.1 billion in 2024 and is projected to reach USD 22.9 billion by 2034, growing at a CAGR of 14% during the forecast period.
Key Highlights:
• Market Size 2024: USD 6.1 billion
• Forecast 2034: USD 22.9 billion
• CAGR (2024-2034): 14%
• Primary Drivers: Rising geriatric population, increasing incidence of age-related diseases, and breakthroughs in drug discovery.
• Challenges: High R&D costs, regulatory hurdles, and ethical debates around longevity medicine.
• Leading Players: Novartis, Calico Life Sciences (Alphabet), GlaxoSmithKline, Unity Biotechnology, Juvenescence, Elysium Health, BioAge Labs, and Geron Corporation.
The market is moving beyond cosmetics and nutraceuticals into science-driven therapeutics targeting the root causes of aging.
Segmentation Analysis
By Drug Class:
• Senolytics (targeting senescent cells)
• NAD+ boosters
• mTOR inhibitors
• Hormone replacement therapies
• Antioxidants & mitochondrial drugs
• Others (stem cell-based, gene therapies)
By Mechanism of Action:
• Cellular senescence modulation
• Genomic stability enhancers
• Immune system regulators
• Mitochondrial function boosters
• Telomere stabilizers
By Application:
• Cardiovascular health
• Neurodegenerative diseases (Alzheimer's, Parkinson's)
• Oncology (age-related cancers)
• Dermatology & aesthetics
• General longevity enhancement
By End-User:
• Hospitals & clinics
• Specialty anti-aging centers
• Research & academic institutes
• Pharmaceutical & biotech companies
Summary:
While dermatology and aesthetics remain visible applications, the strongest momentum lies in neurology, oncology, and systemic aging interventions. Senolytics and NAD+ boosters are leading the therapeutic pipeline, while stem cell and gene therapies represent high-potential frontiers.
Explore Full Report here: https://exactitudeconsultancy.com/reports/72631/anti-aging-drugs-market
Regional Analysis
North America
• Largest market due to cutting-edge biotech innovation, high healthcare spending, and strong venture capital investment in longevity research.
• U.S. leads with active clinical trials in senolytics and NAD+ modulators.
Europe
• Significant adoption in Germany, UK, and Switzerland, with government and private sector initiatives in regenerative medicine.
• EU's supportive stance on healthy aging programs fosters growth.
Asia-Pacific
• Fastest-growing market, led by Japan, China, and South Korea.
• Increasing aging population, rising interest in longevity medicine, and government-backed healthcare R&D drive adoption.
Middle East & Africa
• Growing healthcare modernization, with anti-aging treatments expanding in GCC nations.
• Early adoption in private specialty clinics.
Latin America
• Brazil and Mexico emerging markets with rising consumer demand for both therapeutic and aesthetic anti-aging solutions.
Summary:
While North America dominates, Asia-Pacific is expected to post the fastest CAGR (15%+), supported by rapid demographic aging and strong interest in longevity science.
Market Dynamics
Key Growth Drivers:
• Rising global aging population and prevalence of age-related diseases.
• Advances in biotechnology, stem cell therapies, and gene editing.
• Increasing investment from venture capital and tech giants.
• Expanding demand for both therapeutic and preventive anti-aging solutions.
Key Challenges:
• Ethical and regulatory uncertainties around life-extension therapies.
• High clinical trial costs and long timelines.
• Limited awareness and affordability in developing regions.
Latest Trends:
• Surge in senolytics development to clear senescent cells linked with aging.
• Growth of NAD+ boosters (nicotinamide riboside, NMN supplements) for cellular rejuvenation.
• Increased collaboration between tech firms and biotech companies for AI-driven drug discovery.
• Rising adoption of precision medicine for personalized longevity treatments.
Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=72631
Competitor Analysis
Major Players in the Anti-Aging Drugs Market:
• Novartis - Advancing mTOR inhibitors with applications in longevity.
• Calico Life Sciences (Alphabet) - Focused on aging biology research and drug discovery.
• GlaxoSmithKline (GSK) - Active in senolytics and mitochondrial therapies.
• Unity Biotechnology - Pioneer in senolytic drug development.
• Juvenescence Ltd. - Investing heavily in longevity biotech startups.
• Elysium Health - Known for NAD+ supplements and cellular health products.
• BioAge Labs - Using AI-driven approaches for age-related disease drug discovery.
• Geron Corporation - Developing telomerase-based therapies.
Competitive Summary:
The market is characterized by high innovation and early-stage R&D competition. Biotech startups dominate the pipeline, while large pharma companies are increasingly collaborating or acquiring smaller firms. Success depends on clinical trial breakthroughs, regulatory approvals, and long-term safety data.
Conclusion
The Anti-Aging Drugs Market is transitioning from niche interest to mainstream healthcare, projected to reach USD 22.9 billion by 2034. As science advances from cosmetics to true longevity therapeutics, opportunities for innovation and investment are vast.
Key Takeaways:
• Market to grow at 14% CAGR (2024-2034).
• Senolytics and NAD+ boosters lead the therapeutic landscape.
• North America dominates, but Asia-Pacific is the fastest-growing region.
• Market competition is driven by biotech startups, partnerships, and AI-enabled drug discovery.
• Future opportunities lie in gene therapies, stem cell treatments, and personalized longevity programs.
As aging becomes one of the most pressing global health challenges, anti-aging drugs are poised to transform how societies approach health, vitality, and quality of life, setting the stage for a new era of regenerative medicine and healthy longevity.
This report is also available in the following languages : Japanese (抗老化薬市場), Korean (노화 방지 약물 시장), Chinese (抗衰老药物市场), French (Marché des médicaments anti-âge), German (Markt für Anti-Aging-Medikamente), and Italian (Mercato dei farmaci anti-invecchiamento), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/72631/anti-aging-drugs-market#request-a-sample
Our More Reports:
Telehealth Services Market
https://exactitudeconsultancy.com/reports/73692/telehealth-services-market
Metaverse in Healthcare Market
https://exactitudeconsultancy.com/reports/73693/metaverse-in-healthcare-market
Electronic Health Records Market
https://exactitudeconsultancy.com/reports/73694/electronic-health-records-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release A combination of anti-aging drug increases the lifetime of mice by 30% and gives promise for human longevity here
News-ID: 4202173 • Views: …
More Releases from Exactitude Consultancy
FDA decision on relacorilant for Cushing's expected by year's end
Introduction
Cushing's syndrome is a rare but serious endocrine disorder caused by prolonged exposure to high cortisol levels. It can occur due to long-term use of corticosteroid medications or because of tumors that produce excess adrenocorticotropic hormone (ACTH). Symptoms such as weight gain, hypertension, diabetes, osteoporosis, and psychological changes significantly impact patients' quality of life.
Though rare, Cushing's syndrome has become an important therapeutic focus in endocrinology because of the severe health…
RNA Extraction and Purification Market to Reach USD 5.4 Billion by 2034
The global RNA Extraction and RNA Purification Market is a critical segment of the molecular biology and life sciences ecosystem, enabling breakthroughs in genomics, diagnostics, drug development, and therapeutic research. RNA purification is essential for applications such as next-generation sequencing (NGS), polymerase chain reaction (PCR), transcriptome analysis, biomarker discovery, and vaccine development. The COVID-19 pandemic underscored the importance of robust RNA extraction technologies for viral detection, while ongoing advances in…
Advances in the Study of Macular Degeneration Addressing the Rising Global Burde …
Introduction
Macular degeneration, particularly age-related macular degeneration (AMD), is one of the leading causes of irreversible vision loss among adults over 50. It affects the macula - the central portion of the retina responsible for sharp, detailed vision. With aging populations and lifestyle-related risk factors on the rise, the global prevalence of AMD is growing at an alarming rate.
While treatments such as anti-VEGF (vascular endothelial growth factor) injections have transformed disease…
Baby healed in world's first gene-editing therapy; Indian-origin doctor plays ke …
Introduction
Genome editing has transitioned from a theoretical possibility to a transformative therapeutic reality. With tools such as CRISPR-Cas9, TALENs, and zinc finger nucleases (ZFNs), scientists can now make precise modifications to DNA sequences, correcting mutations at their source. This unprecedented capability is paving the way for treatments that cure genetic disorders, rather than just managing symptoms.
The genome editing therapy market is poised for strong growth as pharmaceutical and biotech firms…
More Releases for NAD+
Test NAD+ at Home: CELFULL Launches Science-Backed Aging Tracker
Coral Springs, FL - Aug 20, 2025 - At the end of 2020, CELFULL launched the Hebe Youth Project, the world's first large-scale, real-world NAD+ supplementation study. The initiative aims to establish accurate baseline NAD+ values, assess aging levels, explore optimal supplementation strategies, and quantify the relationship between NAD+ and aging.
Image: https://www.globalnewslines.com/uploads/2025/08/4367a5b1043ece7e6611155ff767e121.jpg
BRET sensor correlation, analyte colors, and molecular interaction.
Over five years, CELFULL has collected more than 100,000 samples, establishing precise…
Nicotinamide Adenine Dinucleotide (NAD) Industry Outlook | Growth Opportunities …
Market Size and Growth
✦ The market was valued at approximately, reflecting strong, sustained growth. at a CAGR of 11.25 % during the forecast period (2024-2031)
✦ The driving force behind this expansion is a combination of surging global demand, technological advancements, and significant investments in new infrastructure projects.
Mergers and acquisition
ChromaDex rebranded as Niagen Bioscience in March 2025 to emphasize its focus on NAD+ science and its flagship ingredient, Niagen.
In early…
NAD-based Anti-Aging Market Surges as Next-Gen Liposomal NMN and NAD Nasal Spray …
InsightAce Analytic Pvt. Ltd. announces the release of the market assessment report on "Global NAD-based Anti-Aging Market Size, Share & Trends Analysis Report By Type (Supplements (Oral NAD Dietary Supplements, Topical NAD Supplements (Creams, Serums, Lip Creams, Eye Creams)) Therapeutic Products (NAD Nasal Spray, and NAD injections/NAD IV)), Type of Aging (Cellular Aging, Immune Aging, Metabolic Aging, Others), Distribution Channel (Supermarkets & Hypermarkets, Specialty Stores, Convenience Stores, Pharmacies/Clinics, Online Stores)…
NAD in Georgia Launches Exclusive BR+NAD Outpatient Treatment Offer
NAD in Georgia introduces BR+NAD, an innovative 10-day outpatient treatment for addiction with a 90% effectiveness rate. Unlike traditional inpatient programs, it offers faster recovery, minimal side effects, and reduced costs ($12,500 vs. $27,000+). This holistic therapy, including NAD+ treatment, supports detox, cravings reduction, and brain health restoration, providing a sustainable, cost-effective solution for long-term recovery.
Alpharetta, GA - May 14, 2025 - NAD in Georgia proudly unveils its BR+NAD outpatient…
NAD+ Enhancer Market: An Extensive Analysis Predicts Significant Future Growth
NAD+ Enhancer Market Overview :
The NAD+ Enhancer Market is significant growth determined by increasing consumer awareness of cellular health, aging-related research, and longevity-focused nutraceuticals. NAD+ (Nicotinamide Adenine Dinucleotide) plays a crucial role in cellular metabolism and energy production, making NAD+ enhancers highly sought after in anti-aging, cognitive health, and sports performance supplements. Advancements in biotechnology and clinical studies supporting NAD+ restoration's benefits have further fueled market expansion. Key players are…
NAD Electronics Introduces the C 379 HybridDigital DAC Amplifier
The new addition to the Classic Series combines innovation and value to deliver refined performance and sound quality.
MAY 2, 2024 - MUNICH, GERMANY - NAD Electronics, a leading manufacturer in high-performance audio, today announces the launch of its new Classic Series amplifier, the C 379 HybridDigital DAC Amplifier at the HIGH END Munich International Audio Show. The C 379 builds on NAD's commitment to innovation and value-driven performance with a…
